-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

201.O1.6 201. Granulocytes, Monocytes and Macrophages I

Granulocytes, Monocytes and Macrophages Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 2:45 PM-4:15 PM
W340, Level 3 (Orange County Convention Center)
Moderators:
Niels Borregaaard, University of Copenhagen and Peter Gaines, Ph.D., University of Massachusetts Lowell

Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Athalia Rachel Pyzer, MD1*, Dina Stroopinsky, PhD1*, Hasan Rajabi, PhD2*, Jacalyn Rosenblatt, MD1, Maxwell Douglas Coll1*, Salvia Jain, MD3, Kristen Anna Palmer1*, Ashujit Tagde, PhD, BPharm2*, Katarina Luptakova, MD1, Malgorzata McMasters, MD1*, James D. Levine, MD1, Robin Joyce, MD4, Jon E. Arnason, MD1, Myrna Rita Nahas, MD1*, Rebecca Karp Leaf, MD1, Abigail Washington1*, Michal Bar-Natan, M.D1*, Poorvi Somaiya Dutt1*, Donald Küfe, MD2* and David E. Avigan, MD1

1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Malignant Hematology and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
4Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA

3:00 PM

Lisa Andzinski, PhD1*, Mozhgan Dehghan Harati2*, Edyta Zyla2*, Nadine Kasnitz1*, Stephanie Stahnke1*, Ching-Fang Wu, MD, PhD3*, Marcus Gereke, PhD4*, Maren von Köckritz-Blickwede, PhD5*, Bastian Schilling, MD6*, Sven Brandau, PhD7*, Lothar Kanz, MD8, Karl Welte, MD9*, Siegfried Weiss, PhD1*, Julia Skokowa, Prof. Dr.10* and Jadwiga Jablonska, PhD11*

1Molecular Immunology, Helmholtz Centre for Infection Research, HZI, Braunschweig, Germany
2Division of Translational Oncology, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology University Hospital Tuebingen, Tuebingen, Germany
3Division of Nephrology, Department of Internal Medicine, E-DA Hospital/I-Shou University, Kaohsiung, Taiwan
4Immune Regulation, Helmholtz Centre for Infection Research, HZI, Braunschweig, Germany
5Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany
6Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany
7Department of Otorhinolaryngology, University Hospital, University of Duisburg-Essen, Essen, Germany
8Dept. of Medicine II, University of Tübingen, Tübingen, Germany
9University Children’s Hospital Tuebingen, Tuebingen, Germany
10Division of Translational Oncology, Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
11Division of Translational Oncology, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany

3:15 PM

Yanling Xiao, MD, PhD1*, Joanna Aleksandra Grabowska, MSc1*, Riccardo Mezzadra, PhD student1*, Maarten J. van Tol, PhD2*, Arjan C Lankester, MD, PhD2 and Jannie Borst, PhD1*

1Division of Immunology, The Netherlands Cancer Institute, Amsterdam, Netherlands
2Dept. of Pediatrics, Leiden University Medical Center, Leiden, Netherlands

3:30 PM

Alyssa Cull, MSc1*, Brooke Snetsinger, MSc1* and Michael J. Rauh, MD, PhD2

1Dept. Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada
2Department of Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada

3:45 PM

Yaping Sun, MD, PhD1, Matthew Iyer, MD, PhD2,3*, Meng Zhao, PhD4*, Richard McEachin, PhD2*, Yi-Mi Wu, PhD3*, Xuhong Cao, MS3*, Katherine Oravecz-Wilson, MS1*, Cynthia Zajac, BS1*, Nathan Mathewson, PhD1,5, Julia Wu, BS1,5*, Corinne Rossi, MD1*, Tomomi Toubai, M.D., Ph.D.1, Zhaohui Qin, PhD4*, Arul Chinnaiyan3,6* and Pavan Reddy, MD1

1Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
2Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI
3Ctr for Translational Pathology, Howard Hughes Medical Institute, Ann Arbor, MI
4Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA
5Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, MI
6Department of Pathology, University of Michigan, Ann Arbor, MI

4:00 PM

Houra Loghmani-khouzani, PhD1*, Maksim Klimiankou, PhD1*, Siarhei Kandabarau, BS2*, Cornelia Zeidler, MD, MPH3*, Karl Welte, Prof. Dr. med.4 and Julia Skokowa, Prof. Dr.1*

1Division of Translational Oncology, Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
2Department of Molecular hematopoiesis, Hannover Medical School, Hannover, Germany
3Severe Chronic Neutropenia International Registry, Department of Molecular Hematopoiesis, Medical School Hannover, Hannover, Germany
4Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, University Hospital Tuebingen, Tuebingen, Germany

*signifies non-member of ASH